Skip to content

The acute effect of percutaneous tibial nerve stimulation on postural control

The acute effect of percutaneous tibial nerve stimulation on postural control: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17765352
Enrollment
39
Registered
2024-12-13
Start date
2024-12-16
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postural control Other

Interventions

Participants were randomly and equally assigned to each group using a 1:1:1 design via the Random.org program. The therapist was informed only through sealed envelopes. Group Percutaneous tibial nerv
PRIM Physio®, Madrid, Spain) will be used for this procedure. Participants will be positioned prone with their feet hanging off the edge of the treatment table. The posterior tibial nerve will be loc
GE Healthcare, Chicago, IL, USA) for the insertion of a needle (0.30 mm x 40 mm). Prior to insertion, the skin surface will be cleaned with alcohol. The procedure will be performed by a physiotherapis

Sponsors

Fundación Universitaria San Pablo CEU
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Healthy young adults 2. Engage in at least 150 minutes of moderate aerobic activity per week (or the equivalent in vigorous activity), or at least 20 minutes per week of vigorous physical activity

Exclusion criteria

Exclusion criteria: 1. An injury affecting balance in one limb within the past year that prevented participation in sports for at least 1 day 2. A Personal Psychological Apprehension Scale (EPPAS) score >37.5 3. Commonly accepted contraindications for invasive physiotherapy techniques, including chronic joint disease, surgery, prosthetics, or osteosynthesis in the intervention area, as well as cardiac diseases, neoplasms, coagulopathies, and the use of certain medications 4. Any contraindication to the puncture itself 5. Epilepsy

Design outcomes

Primary

MeasureTime frame
Postural control will be measured using a force platform (Accupower; AMTI, Watertown, MA, USA) with a sampling frequency of 1000 Hz. Participants will stand on one leg, with their hands on their hips and their gaze fixed on a point 2 meters away. The tests will be conducted with eyes open and closed. For each condition, three attempts will be made. Each test will last 30 seconds, followed by a 1-minute rest period. The displacement of the center of pressure will be analyzed using linear variables: total center of pressure displacement (DOT) and the total length of its path; total displacement area (Area); mediolateral displacement (Displ_ML) and anteroposterior displacement (Displ_AP); and the amplitude of the center of pressure in the mediolateral (Ampl_ML) and anteroposterior (Ampl_AP) directions, defined as the distance between the minimum and maximum values. 1. Variable DOT measured using force platform at baseline, 0, 2, 24 and 48 h 2. Variable Area measured using force platform at baseline, 0, 2, 24 and 48 h 3. Variable Displ_ML measured using force platform at baseline, 0, 2, 24 and 48 h 4. Variable Displ_AP measured using force platform at baseline, 0, 2, 24 and 48 h 5. Variable Ampl_ML measured using force platform at baseline, 0, 2, 24 and 48 h 5. Variable Ampl_AP measured using force platform at baseline, 0, 2, 24 and 48 h

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

Spain

Contacts

Public ContactMiguel Rodriguez Rosal
mrodriguezr@ceu.es+34 954 48 80 00

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026